Alyeska Investment Group’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-49,553	Closed	-$639K	–	479
2018 Q1	$639K	Sell	49,553 -447	-0.9%	-$5.76K	0.01%	377
2017 Q4	$554K	Hold	50,000	–	–	﹤0.01%	372
2017 Q3	$628K	Buy	+50,000	New	+$628K	﹤0.01%	406